MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mnm.0000000000002231

Медицинская библиотека · Nuclear medicine communications · 2026

Treatment response evaluation in extraspinal musculoskeletal tuberculosis using molecular imaging (18F-fluorodeoxyglucose PET/computed tomography): a prospective observational study.

Banjara Roshan, Sankhwar Dilip Kumar, Upadhyay Ashish Dutt, George Jaiben, Kumar Rakesh, Shankar Vivek, Sampath Kumar Venkatesan, Khan Shah Alam

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

The aim of the study was to evaluate the role of 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) in monitoring treatment response and determining treatment end points in patients with extraspinal musculoskeletal tuberculosis (MSK-TB) receiving anti-tubercular therapy (ATT).

METHODS

In this prospective observational study, 62 patients with extraspinal MSK-TB underwent baseline 18F-FDG PET/CT before ATT, with follow-up scans at 6, 12, and 18 months. Total lesion glycolysis (TLG), maximum standardized uptake value (SUVmax), and lesion-to-liver standardized uptake value ratio (SUVR) were recorded. Clinical, laboratory, and MRI findings were used as reference standards for healing. Receiver operating characteristic analysis identified PET/CT parameters associated with ATT beyond 18 months.

RESULTS

Fifty-one patients completed the final PET/CT follow-up. Significant reductions in TLG, SUVmax, and SUVR were observed during treatment (all P < 0.05). ROC analysis demonstrated that a ≤43% reduction in TLG, ≤46% reduction in SUVmax, and ≤26% reduction in SUVR between baseline and 6-month scans, and a ≤66% reduction in TLG, ≤36% reduction in SUVmax, and ≤30% reduction in SUVR between baseline and 12-month scans, were associated with the requirement for ATT beyond 18 months. The mean time to complete clinicoradiological healing was 19.23 ± 1.49 months, whereas the mean time to complete metabolic response on PET/CT was 18.54 ± 2.27 months, with no statistically significant difference (P = 0.30).

CONCLUSION

18F-FDG PET/CT is a valuable tool for monitoring treatment response in extraspinal MSK-TB. Early changes in PET/CT parameters may predict treatment duration, and PET/CT findings closely correlate with disease healing, supporting its use in guiding individualized ATT duration.

Для цитирования: Banjara Roshan, Sankhwar Dilip Kumar, Upadhyay Ashish Dutt, George Jaiben, Kumar Rakesh, Shankar Vivek, Sampath Kumar Venkatesan, Khan Shah Alam. Treatment response evaluation in extraspinal musculoskeletal tuberculosis using molecular imaging (18F-fluorodeoxyglucose PET/computed tomography): a prospective observational study.. Nuclear medicine communications. 2026. DOI: 10.1097/mnm.0000000000002231.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.